LFFS | DMFS | OS | ||||
---|---|---|---|---|---|---|
Characteristic | HR (95 % CI) | P* | HR (95 % CI) | p | HR (95 % CI) | |
Age (>50 vs. ≤50) | 0.980 | 0.774 | 0.210 | |||
Gender | 0.602 | 0.780 | 0.794 | |||
Location | 0.560 | 0.453 | 0.506 | |||
Histology | 0.621 | <0.001 | <0.001 | |||
Rhabdomyosarcoma | 1.00 | 1.00 | ||||
Fibrosarcoma | 0.128 (0.029–0.569) | 0.012 | 0.142 (0.039–0.510) | 0.003 | ||
MFH | 0.574 (0.281–1.174) | 0.088 | 0.516 (0.254–1.047) | 0.067 | ||
Liposarcoma | 0.161 (0.069–0.378) | <0.001 | 0.186 (0.088–0.392) | <0.001 | ||
Others | 0.407 (0.154–1.074) | 0.074 | 0.426 (0.169–1.073) | 0.070 | ||
Tumor size (cm) | 0.033 | 0.066 | 0.003 | |||
≤5 | 1.00 | 1.00 | ||||
>5 | 1.815 (1051–3.138) | 2.638 (1.392–4.998) | ||||
Grade | 0.147 | 0.259 | 0.400 | |||
Margin status | 0.002 | 0.143 | <0.001 | |||
Negative | 1.00 | 1.00 | 1.00 | |||
Positive | 2.595 (1.432–4.702) | 2.187 (1.055–4.536) | 3.942 (2.233–6.959) | |||
Lymph node status | 0.909 | 0.272 | 0.582 | |||
Chemotherapy | 0.687 | 0.894 | 0.719 | |||
Radiotherapy | 0.001 | 0.769 | 0.017 | |||
No | 1.00 | 1.00 | ||||
Yes | 0.408 (0.235–0.707) | 0.512 (0.296–0.886) |